IQVIA (NYSE:IQV) Given New $210.00 Price Target at Mizuho
IQVIA (NYSE:IQV – Free Report) had its price objective lowered by Mizuho from $242.00 to $210.00 in a research report report published on Wednesday morning,Benzinga reports. Mizuho currently has an outperform rating on the medical research company’s stock. IQV has been the topic of several other research reports. Stephens initiated coverage on shares of IQVIA […]
